These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Low-grade Serous Carcinoma of the Ovary: Clinicopathologic Analysis of 52 Invasive Cases and Identification of a Possible Noninvasive Intermediate Lesion. Ahn G; Folkins AK; McKenney JK; Longacre TA Am J Surg Pathol; 2016 Sep; 40(9):1165-76. PubMed ID: 27487741 [TBL] [Abstract][Full Text] [Related]
7. MR imaging findings of low-grade serous carcinoma of the ovary: comparison with serous borderline tumor. Kawaguchi M; Kato H; Hatano Y; Tomita H; Hara A; Suzui N; Miyazaki T; Furui T; Morishige KI; Matsuo M Jpn J Radiol; 2020 Aug; 38(8):782-789. PubMed ID: 32246351 [TBL] [Abstract][Full Text] [Related]
8. Differences in ultrasound features of papillations in unilocular-solid adnexal cysts: a retrospective international multicenter study. Landolfo C; Valentin L; Franchi D; Van Holsbeke C; Fruscio R; Froyman W; Sladkevicius P; Kaijser J; Ameye L; Bourne T; Savelli L; Coosemans A; Testa A; Timmerman D Ultrasound Obstet Gynecol; 2018 Aug; 52(2):269-278. PubMed ID: 29119698 [TBL] [Abstract][Full Text] [Related]
12. Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases. Vang R; Hannibal CG; Junge J; Frederiksen K; Kjaer SK; Kurman RJ Am J Surg Pathol; 2017 Jun; 41(6):725-737. PubMed ID: 28248817 [TBL] [Abstract][Full Text] [Related]
13. Clinical and ultrasound characteristics of surgically removed adnexal lesions with largest diameter ≤ 2.5 cm: a pictorial essay. Di Legge A; Pollastri P; Mancari R; Ludovisi M; Mascilini F; Franchi D; Jurkovic D; Coccia ME; Timmerman D; Scambia G; Testa A; Valentin L Ultrasound Obstet Gynecol; 2017 Nov; 50(5):648-656. PubMed ID: 28004457 [TBL] [Abstract][Full Text] [Related]
14. Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver. Emmanuel C; Chiew YE; George J; Etemadmoghadam D; Anglesio MS; Sharma R; Russell P; Kennedy C; Fereday S; Hung J; Galletta L; Hogg R; Wain GV; Brand A; Balleine R; MacConaill L; Palescandolo E; Hunter SM; Campbell I; Dobrovic A; Wong SQ; Do H; Clarke CL; Harnett PR; Bowtell DD; deFazio A; Clin Cancer Res; 2014 Dec; 20(24):6618-30. PubMed ID: 25316818 [TBL] [Abstract][Full Text] [Related]
15. Ultrasound features and clinical outcome of patients with malignant ovarian masses diagnosed during pregnancy: experience of a gynecological oncology ultrasound center. Moro F; Mascilini F; Pasciuto T; Leombroni M; Li Destri M; De Blasis I; Garofalo S; Scambia G; Testa AC Int J Gynecol Cancer; 2019 Sep; 29(7):1182-1194. PubMed ID: 31326950 [TBL] [Abstract][Full Text] [Related]
17. Stage II to IV low-grade serous carcinoma of the ovary is associated with a poor prognosis: a clinicopathologic study of 32 patients from a population-based tumor registry. Ali RH; Kalloger SE; Santos JL; Swenerton KD; Gilks CB Int J Gynecol Pathol; 2013 Nov; 32(6):529-35. PubMed ID: 24071867 [TBL] [Abstract][Full Text] [Related]
18. MRI appearance of ovarian serous borderline tumors of the micropapillary type compared to that of typical ovarian serous borderline tumors: radiologic-pathologic correlation. Nakai G; Yamada T; Yamamoto K; Hirose Y; Ohmichi M; Narumi Y J Ovarian Res; 2018 Jan; 11(1):7. PubMed ID: 29321056 [TBL] [Abstract][Full Text] [Related]
20. Ovarian Low-grade Serous Carcinoma: A Clinicopathologic Study of 33 Cases With Primary Surgery Performed at a Single Institution. Okoye E; Euscher ED; Malpica A Am J Surg Pathol; 2016 May; 40(5):627-35. PubMed ID: 26900814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]